Use of midazolam ('Dormicum') and flumazenil ('Anexate') in paediatric bronchology.
One hundred and seven bronchological examinations using midazolam narcosis in association with flumazenil were carried out in 100 children (mean age 3.5 years, range 4 months to 14 years) suffering from chronic non-specific lung disease. Rigid bronchoscopy was followed in 49 cases by bronchography. All patients were premedicated with atropine followed by midazolam (0.2 mg/kg intravenously). Ventilation was carried out with nitrous oxide and oxygen in 47 children and with oxygen only in 60 patients. After 3 mins, suxamethonium (2 mg/kg intravenously) was given for muscle relaxation and intubation carried out. Fifty-one of the children ventilated with oxygen only also received fentanyl (0.002 mg/kg intramuscularly), at the same time as atropine, to provide analgesia. After extubation, all patients were given flumazenil (0.1 to 0.2 mg intravenously) to reverse the effects of midazolam. The results showed that midazolam provided effective sedation and comfortable sleep (mean examination time 12 min 50 sec) and it was considered that the method using fentanyl rather than nitrous oxide for analgesia was the most satisfactory one. Patients awakened promptly (1 min) after flumazenil and quick and effective expectoration was noted, particularly important in those who had undergone bronchography. No complications were observed. Since this investigation, a further 500 bronchoscopics have been carried out using this method with the same results. Even though no narcosis equipment is required, it is recommended that, as with other procedures involving narcosis with muscle relaxation, bronchoscopy with these drugs should not be used in out-patients.
Baktai
G
G
Pediatric Institute Szabadsághegy, Budapest, Hungary.
Székely
E
E
Márialigeti
T
T
Kovács
L
L
D000758:Anesthesia; D001285:Atropine / Q000008:administration & dosage; D001999:Bronchoscopy; D002675:Child, Preschool; D002908:Chronic Disease; D004334:Drug Administration Schedule; D004562:Electrocardiography; D005240:Feasibility Studies; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage; D005442:Flumazenil; D006801:Humans; D007223:Infant; D008171:Lung Diseases / Q000175:diagnosis*; D008297:Male; D008874:Midazolam; D009609:Nitrous Oxide / Q000008:administration & dosage; D010100:Oxygen / Q000008:administration & dosage; D011292:Premedication; D011674:Pulse / Q000187:drug effects; D013390:Succinylcholine / Q000008:administration & dosage
D005442:Flumazenil; D001285:Atropine; D013390:Succinylcholine; D009609:Nitrous Oxide; D008874:Midazolam; D010100:Oxygen; D005283:Fentanyl